HOUSTON—U.S. Physical Therapy Inc. (NYSE:USPH) Director Bernard A. Harris Jr. recently sold 2,000 shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $92.95, amounting to a total transaction value of $185,900. Following this sale, Harris retains direct ownership of 16,726 shares.
The transaction occurred on November 12, 2024. The shares were sold in multiple transactions at prices ranging from $92.87 to $93.01 per share. Harris's remaining shares include 712 restricted shares, with restrictions set to lapse in early 2025, contingent upon his continued role as a director.
In other recent news, U.S. Physical Therapy, Inc. disclosed its third quarter financial results for 2024, led by Chairman and CEO Chris Reading, alongside other key executives. Although specific financial details were not provided in the summary, the company made forward-looking statements, cautioning that actual results may differ materially from those anticipated. These statements, a staple in such presentations, are designed to inform investors about the company's expectations for future performance, while also acknowledging inherent risks and uncertainties. For a deeper understanding of the potential risks that could impact U.S. Physical Therapy's performance, the company referred investors to its SEC filings. Details from the customary question-and-answer session following the presentation were not included in the summary. These are some of the recent developments for U.S. Physical Therapy, Inc.
InvestingPro Insights
U.S. Physical Therapy Inc. (NYSE:USPH) has shown resilience in its financial performance, which may provide context to Director Bernard A. Harris Jr.'s recent stock sale. According to InvestingPro data, the company's revenue growth stands at 9.2% over the last twelve months, with a notable 12.01% increase in quarterly revenue. This growth trajectory aligns with an InvestingPro Tip indicating that net income is expected to grow this year.
Despite the recent insider sale, USPH maintains a strong market position with a market capitalization of $1.39 billion. The company's commitment to shareholder returns is evident, as highlighted by another InvestingPro Tip: USPH has raised its dividend for 4 consecutive years and has maintained dividend payments for 14 consecutive years. This consistent dividend policy may provide some reassurance to investors in light of the director's stock sale.
It's worth noting that USPH is trading at a high earnings multiple, with a P/E ratio of 99.18. However, the company's adjusted P/E ratio for the last twelve months is lower at 57.57, which may suggest that the market is pricing in future growth expectations.
For investors seeking a more comprehensive analysis, InvestingPro offers additional insights with 10 more tips available for USPH, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.